The allotment for Anthem Biosciences IPO is now complete. Investors can check their status on KFin Technologies website. The ...

The IPO, which opened for subscription on 14 July and closed on 16 July, witnessed strong investor interest, particularly ...

AM, GIFT Nifty futures were trading 14 points higher at 25,260, indicating a flat to positive start for the bourses.

Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...

Since this IPO was fully an OFS, the contract research, development and manufacturing company will not receive any funds, ...

Anthem Biosciences' initial public offering (IPO) was subscribed 63.86 times, largely due to strong support from qualified institutional buyers (QIBs).

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.

Anthem Biosciences’ ₹3,395-crore IPO saw strong investor demand, with overall subscription at 63.86x, signaling robust interest in the pharma CDMO sector.

Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while ...

Anthem Biosciences Ltd's IPO was subscribed 63.86 times by closing day, driven by institutional buyers. The Rs 3,395-crore ...

Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the ...

According to market observers, unlisted shares of Anthem Biosciences Ltd are currently trading at Rs 733 against its upper ...